In a Tough Year, Viking Global Stages an October Comeback
Three major funds help put the firm in the black, despite a major bet on ravaged health care stocks, including Valeant Pharmaceuticals.
Stephen TaubNovember 4, 2015
O. Andreas Halvorsen, Viking Global Investors (Bloomberg)Viking Global Investors posted decent gains across all three of its funds in October. Given its portfolio, this is a big victory. Viking Global
To continue reading, subscribe now to Premium Journalism. Already a subscriber? login.